نتایج جستجو برای: hereditary breast cancer

تعداد نتایج: 1055993  

Journal: :iranian journal of blood and cancer 0
mehrdad zeinalian department of genetics and molecular biology, school of medicine, isfahan university of medical sciences, isfahan, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی اصفهان (isfahan university of medical sciences)سازمان های دیگر: ala cancer prevention and control center, isfahan, iran nafiseh heidarzadeh ala cancer prevention and control center, isfahan, iran homayoun naji ala cancer prevention and control center, isfahan, iran, and department of anesthesia, nursing school, isfahan university of medical sciences, isfahan, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی اصفهان (isfahan university of medical sciences) mohammad reza sharbafchi department of psychiatry, school of medicine, isfahan university of medical sciences; isfahan, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی اصفهان (isfahan university of medical sciences)

background: breast cancer is one of the most common malignancies among iranian women; however, its clinicopathological feature is uncertain. we pioneered a genetic counseling program among patients with breast cancer and their families in isfahan. this is the first report of this program. methods: this was a descriptive cross-sectional study on women with breast cancer registered in ala cancer ...

Journal: :modares journal of medical sciences: pathobiology 2014
mojgan ataei-kachouei javad nadaf mohammad taghi akbari morteza atri jacek majewski

objective: since the identification of the two highly penetrant dominantly inherited genes, brca1/2, in the 1990s, a number of other genes have been identified which account for approximately 25% of the genetic basis for hereditary breast cancer. at least 75% are unidentified. the goal of this study is to investigate the presence or absence of a recessive pattern of inheritance in this heteroge...

Introduction: Breast cancer is the most common malignancy in women worldwide. BRCA1 is a tumor suppressor gene that is involved in DNA-damage repair. One of the significant risk factors of breast cancer is the family history. BRCA1 gene consists of 24 exons that encode a protein with 1863 amino acids. Exon 11 is the largest exons and most of the disease-linked mutations have been found in it. I...

Journal: :archives of breast cancer 0
lamia elfandi school of biological sciences, the libyan academy, tripoli, libya ghada said department of genetic engineering, biotechnology research center (btrc), twisha, tripoli, libya saleh suleiman saleh department of genetic engineering, biotechnology research center (btrc), twisha, tripoli, libya mohamed marwan faculty of sciences, tripoli university, tripoli, libya nabil enattah department of genetic engineering, biotechnology research center (btrc), twisha, tripoli, libya

background: breast cancer is the most common malignancy among women. it is estimated that 1 in 10 women worldwide is affected by breast cancer during their lifetime. in 5 to 10% of breast cancer patients, the disease results from a hereditary predisposition, which can be attributable to mutations in either of two tumor suppressor genes, brca1 and brca2 to a large extent. brca2 6174delt mutation...

Journal: :iranian journal of basic medical sciences 0
nahid karimian fathi medical genetic department medical faculty, tabriz university of medical sciences, tabriz, iran mahmood shekari khaniani medical genetic department medical faculty, tabriz university of medical sciences, tabriz, iran vahid montazeri general surgery department medical faculty, tabriz university of medical sciences, tabriz, iran sima mansoori derakhshan medical genetic department medical faculty, tabriz university of medical sciences, tabriz, iran

objective(s): breast cancer is the most common cancer in women. every year, one million new cases are reported worldwide, representing 18% of the total number of cancer in women. hereditary brca1 and brca2 mutations account for about 60% of inherited breast cancer and are the only known causes of hereditary breast cancer syndrome. the aim of this study was to determine the frequency of brca2 (e...

Mahmood Shekari Khaniani Nahid Karimian Fathi Sima Mansoori Derakhshan Vahid Montazeri,

Objective(s): Breast cancer is the most common cancer in women. Every year, one million new cases are reported worldwide, representing 18% of the total number of cancer in women. Hereditary BRCA1 and BRCA2 mutations account for about 60% of inherited breast cancer and are the only known causes of hereditary breast cancer syndrome. The aim of this study was to determine the frequency of BRCA2 (e...

2015
Camilla Wendt Annika Lindblom Brita Arver Anna von Wachenfeldt Sara Margolin

BACKGROUND Approximately 30 % of all breast cancer is at least partly attributed to hereditary factors. Familial breast cancer is often inherited in the context of cancer syndromes. The most commonly mutated genes are BRCA1 and BRCA2 in hereditary breast and ovarian cancer syndrome. The genetic background in families with hereditary breast cancer without predisposing germ line mutations in BRCA...

Journal: :journal of research in medical sciences 0
maryam sedghi elham esfandiari esmat fazel-najafabadi mansoor salehi abbas salavaty shirin fattahpour

background: th e second leading cause of cancer deaths in women is breast cancer. germline mutations in susceptibility breast cancer gene brca1 increase the lifetime risk of breast cancer. eighty-one large genomic rearrangements (lgrs) have been reported up to date in brca1 gene, and evaluation of these rearrangements helps with precise risk assessment in high-risk individuals. in this study, w...

2005
Andris Gardovskis Arvids Irmejs Edvins Miklasevics Viktors Borosenko Marianna Bitina Inga Melbarde-Gorkusa Andrejs Vanags Grzegorz Kurzawski Janina Suchy Bohdan Górski Janis Gardovskis

INTRODUCTION The aim of the study is to evaluate the incidence and phenotype-genotype characteristics of hereditary breast and ovarian cancer syndromes in Latvia in order to develop the basis of clinical management for patients and their relatives affected by this syndrome. MATERIALS AND METHODS In 2002-2004 in two Latvian oncology hospitals (Liepãja Oncology Hospital and Daugavpils Oncology ...

2009
G. Banneau M. Guedj R. Schiappa F. Petel N. Sévenet I. De Mascarel G. Mac Grogan M. Longy F. Bonnet R.D. Brandão K. Van Roozendaal D. Tserpelis E. Goméz García M.J. Blok K. De Leeneer J. Hellemans J. De Schrijver W. Van Criekinge A. De Paepe P. Coucke K. Claes P. Ghadirian A. Robidoux J.F. Boileau F.S. Côté G. Martin C. Maugard E. Nassif E. Patocskai C. Potvin R. Younan W.D. Foulkes S.A. Narod D. Hanna G. Glendon E. Maloney J. Knight L. Lilge D. Koller I. Andrulis P. Hilbert A. Destrée F. Cavallin C. Verellen–Dumoulin R. Moslehi S. Nolet K. Latour S. Côté N. Dumas M.C. Binet M. Breguet L. Gaboury P. Hamet N. Larouche G. Proulx D. Provencher J. Richard C. Wilmart C. Maugard D.J. Novak L. Amrein J. Reddy L. Wark R. Aloyz S. Mai M.D. Tischkowitz E. Smith E. Tomiak K. Teed E. McCready N. Carson M. Southey M. Tischkowitz Z.L. Teo F. Odefrey N. Sabbaghian G. Byrnes I. Winship M. McCredie G. Giles D. Goldgar W. Foulkes J. Hopper E. Spriggs T. Dyck R. Jobse B. Chordirker A. Chudley S. Marles K. Serfas Julie Richer K. Serfas S. Burgess B. Chodirker M. Vallee F. Lesueur A. Spurdle F. Hogervorst D.E. Goldgar S.V. Tavtigian R.B. van der Luijt A.N.A. Monteiro A.Y. Bronkhorst T.G.W. Letteboer C.J.M. van der Sijs–Bos J.G. Post R. Karchin S.V. Tavtigian D.E. Goldgar P.M. Nederlof H.K.P. van Amstel N.C. van der Merwe E. Jansen van Rensburg G. Michils M. Chmara G. Matthijs E. Legius A. Kwong E.K.O. Ng C.L.P. Wong E.S.K. Ma R.D. Brandao M.J. Blok J. van Harssel A. Romano C. Schrander–Stumpel J. Geraedts M. Zeegers E.B. Goméz García M. Southey F. Odefrey B. Feng G. Mann P. Devilee D. Goldgar V. Joseph M. Gaudet V. Devlin J. Bhatia K. Kosarin G. Bond K. Offit T. Kirchhoff A. Hartmann S. Healey F. Le Calvez–Kelm D. Babikyan G.B. Byrnes J. Hall S. Sangrajrang J.L. Hopper M.C. Southey I.L. Andrulis E.M. John P.J. Oefner G. Chenevix–Trench D. Xing G. Scangas M. Nita X. Xu L. He Y.J.M. Ioffe P.J. Aspuria C.Y. Hedvat M.L. Anderson E. Oliva B.Y. Karlan G. Mohapatra S. Orsulic G. Chêne J. Dauplat N. Lagarde P. Jaffeux Y.J. Bignon F. Penault–Llorca M. Beattie T. Yu B. Crawford M. Metrikin R. Lee J. Campbell H. Storey S. Lillis T. Cullup J. McCauley D. Moore C. Jacobs G. Pichert S.C. Yau S. Abbs S. Dhar P. Cooper S. Hilsenbeck P.A. Kelly C. Noll T. Wang S. Plon L. Dohany W. Ducaine D. Zakalik F. Khan D. Farengo Clark S. Mento G. Grana D. Vicus A. Finch B. Rosen I. Fan L. Bradley I. Cass P. Sun R. Royer B. Karlan J. McLaughlin S.A. Narod D. Gallagher M. Gaudet P. Pal T. Kirchhoff J. Bhatia S. Fine H. Scher P. Scardino L. Norton M. Robson K. Offit L. Lessard L. Al-Salmi A. Izadpanah S. Lupichuk J. Ng K. Blaikie S. Leith T. Power B. Walley C. Kim–Sing M. McCullum J. Pike K. Swenerton T.M. Michelsen A.A. Dahl C.G. Tropé A. Dørum C. Snyder H. Lynch T. Byrski R. Dent D. Zuziak M. Foszczyñska–Kloda J. Gronwald T. Huzarski C. Cybulski J. Lubiñski S.A. Narod R. Manchanda A. Abdelraheem M. Johnson M. Brunell A. Rosenthal S. Gessler C. Brunell E. Benjamin D. Oram I. Jacobs U. Menon J.S.A. Wronzberg S.M. Nikkel E.M. Tomiak C. Ouellette R. Hyde–Lay T. Caulfield K. Bédard E. Lévesque D. Avard J. Simard L. Cavallone S.L. Arcand C.M. Maugard A.M. Mes–Masson P. Ghadirian D. Provencher P.N. Tonin L.M. Chen J.T. Rabban B. Crawford J. Hwang J.K. Chan C.B. Powell M. Dorval K. Bouchard C. Côté S. Camden J. Simard M. Enmore C. Kim–Sing S. Armel L. Bordeleau D. Gilchrist E. Warner A. Chudley E. Lemire P. Ghadirian S. Narod K. Metcalfe E.B. Gomez Garcia J.J.T. van Harssel Y. Detisch R.D. Brandao A.D.C. Paulussen M.J. Blok C.E.P. van Roozendaal K. Metcalfe A. Poll R. Royer M. Llacuachaqui A. Tulman P. Sun S. Narod T. Pal S. Vadaparampil K. Panabaker N. Scanlan T. Paling P. Ainsworth J. Jung N. Poplawski J. Armstrong K. Ryan G. Suthers N. Poplawski K. Ryan J. Armstrong M. Raciti S. Russell G. Suthers D. Trott L.R. Rubin A. Werner–Lin K. Hurley R. Stern A. Phillips M. Sagi K. Offit N. Schonberger S. SenGupta K. Fordham P. Serhal D. Ranieri T. Mamas S. Jaroudi S. Dhanjal G. Kakourou A. Doshi J. Harper J. Delhanty K.M. Shannon G. Chan–Smutko D. Patel M. Jacobs Gabree P.D. Ryan M. Tinker D. Avard B.M. Knoppers J. Simard K. Boycott D. Vicus A. Finch I. Cass B. Rosen J. Murphy I. Fan L. Bradley P. Sun R. Royer J. McLaughlin B. Karlan S.A. Narod R. Lee M. Metrikin G. Joseph D. Braithwaite K. Lamvik S. Jafarieh J. Luce S.H. Teo E. Thirthagiri P. Kang D. Lee S.Y. Yoon N.A.M. Taib M.K. Thong C.H. Yip R. Manchanda U. Menon K. Loggenberg S. Gessler S. Sanderson I. Udeh N. Balogun J. Wardle I. Tomlinson A. McGuire U. Beller I. Jacobs M. Cohen P. Kredow S. Friedman J. DiMillo A. Samson S. Lowry L. Corsini A. Bodurtha S. Verma E. Tomiak H. Etchegary F. Miller S. deLaat B. Wilson J. Carroll M. Cappelli A.F. Howard J.L. Bottorff L.G. Balneaves P. Mor A. Navarro de Souza N. Wong S. Zaor D. Groleau K. Singh X. Li O. Gordon J.P. Gopie T.H.C. Damen R. Timman E.H. Kunst P.J.C. Bresser C. Seynaeve M.B. Menke–Pluijmers M.A.M. Mureau S.O.P. Hofer A. Tibben J. Vos J. Oosterwijk E. Gomez–Garcia F. Menko C.J. van Asperen A.M. Jansen A. Stiggelbout A. Tibben

The opinions expressed in the abstracts are those of the authors and are not to be construed as the opinion of the publisher (Multimed Inc.), the organizers of the Third International Symposium on Hereditary Breast and Ovarian Cancer, or the Hereditary Breast and Ovarian Cancer Foundation. Although the publisher (Multimed Inc.) has made every effort to accurately reproduce the abstracts, Multim...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید